Skip to main content

Joaquin Ruiz Altarejo

Institutions of which they are part

Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca
Joaquin Ruiz Altarejo

Joaquin Ruiz Altarejo

Joaquin Ruiz Altarejo

Institutions of which they are part

Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Related news

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Vall d'Hebron participates in a project to develop innovative microsampling technology, making blood collection more accessible and patient-centered.

Related professionals

García Cao, Isabel

García Cao, Isabel

Predoctoral researcher
Read more
Solsona Rosell, Aina

Solsona Rosell, Aina

Shock, Organ Dysfunction and Resuscitation
Read more
Arranz Figols, Anna

Arranz Figols, Anna

Shock, Organ Dysfunction and Resuscitation
Read more
Fernandez Torrelles, Sara

Fernandez Torrelles, Sara

Research technician
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.